Skip to main content
Clinical Trials/NCT06352658
NCT06352658
Completed
Not Applicable

Efficacy of Different Treatment Modalities for Obstructive Sleep Apnea: a Randomized Controlled Clinical Trial

Nourhan M.Aly1 site in 1 country45 target enrollmentFebruary 1, 2023
ConditionsApnea

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Apnea
Sponsor
Nourhan M.Aly
Enrollment
45
Locations
1
Primary Endpoint
Apnea hypopnea index
Status
Completed
Last Updated
last year

Overview

Brief Summary

This was a prospective randomized controlled clinical trial that aimed to evaluate the efficacy of three treatments for obstructive sleep Apnea OSA:

  1. Conventionally constructed mandibular advancement device (MAD).
  2. Digitally constructed mandibular advancement device (CAD CAM).
  3. Uvulopalatopharyngeoplasty (UPPP).
Registry
clinicaltrials.gov
Start Date
February 1, 2023
End Date
January 10, 2024
Last Updated
last year
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Nourhan M.Aly
Responsible Party
Sponsor Investigator
Principal Investigator

Nourhan M.Aly

Assistant Lecturer of Dental Public Health

University of Alexandria

Eligibility Criteria

Inclusion Criteria

  • Adequate nasal air flow capacity as determined by qualified otolaryngologist
  • Cases showing improvement in airway with mandibular advancement on Acoustic Pharyngometry (AP)
  • Patients with the minimum component of dentition to support MDSA.
  • Patients with the mandibular protrusive movement of more than 5 mm
  • Body mass index (BMI) less than 30 kg/m2

Exclusion Criteria

  • Severe nasal passage obstructions or allergies
  • Obesity (BMI greater than 30 kg/m2 )
  • Cases with Mallampati score greater than Class 1
  • Systemic complications, syndrome, or disease affecting airway
  • Severe periodontal disease

Outcomes

Primary Outcomes

Apnea hypopnea index

Time Frame: 4 months

The AHI measures an average number of apnea and hypopnea episodes that you experience per hour. According to the American Academy of Sleep Medicine (AASM) it is categorized into mild (5-15 events/hour), moderate (15-30 events/hr), and severe (\> 30 events/hr)

Epwoth sleeplness scale (ESS)

Time Frame: 4 months

The ESS is a subjective measure of a patient's sleepiness. The test is a list of eight situations in which the patien rates their tendency to become sleepy on a scale of 0, no chance of dozing, to 3, high chance of dozing. All scores on the ESS fall between 0 and 24. Scores from 0 to 10 reflect normal levels of daytime sleepiness, and scores over 10 are considered to reflect excessive daytime sleepiness.

Oxygen saturation

Time Frame: 4 months

This will be measured using an oximeter. A normal level of oxygen is usually 95% or higher.

Snoring index

Time Frame: 4 months

Snoring index measures the total number of snores per hour of sleep. This is calculated by dividing your total sleeping time by your snoring frequency. The normal range depends on the person's gender and the stage of sleep

Study Sites (1)

Loading locations...

Similar Trials